Bridgeway Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-753,919
| Closed | -$19.1M | – | 1239 |
|
|
2025
Q1 | $19.1M | Buy |
753,919
+58,916
| +8% | +$1.54M | 0.48% | 33 |
|
|
2024
Q4 | $18.4M | Buy |
695,003
+47,293
| +7% | +$1.28M | 0.41% | 45 |
|
|
2024
Q3 | $18.7M | Buy |
647,710
+29,635
| +5% | +$864K | 0.41% | 43 |
|
|
2024
Q2 | $17.3M | Sell |
618,075
-62,587
| -9% | -$1.72M | 0.4% | 43 |
|
|
2024
Q1 | $18.9M | Buy |
680,662
+214,410
| +46% | +$5.95M | 0.39% | 33 |
|
|
2023
Q4 | $13.4M | Buy |
466,252
+96,185
| +26% | +$2.91M | 0.29% | 77 |
|
|
2023
Q3 | $12.3M | Buy |
370,067
+28,256
| +8% | +$999K | 0.3% | 64 |
|
|
2023
Q2 | $12.5M | Buy |
341,811
+270,999
| +383% | +$10.5M | 0.3% | 65 |
|
|
2023
Q1 | $2.89M | Buy |
70,812
+8,500
| +14% | +$367K | 0.08% | 425 |
|
|
2022
Q4 | $3.19M | Sell |
62,312
-153,812
| -71% | -$7.37M | 0.08% | 409 |
|
|
2022
Q3 | $9.46M | Sell |
216,124
-110,300
| -34% | -$5.36M | 0.25% | 84 |
|
|
2022
Q2 | $17.1M | Sell |
326,424
-28,750
| -8% | -$1.47M | 0.39% | 26 |
|
|
2022
Q1 | $18.4M | Buy |
355,174
+175,750
| +98% | +$9.12M | 0.36% | 33 |
|
|
2021
Q4 | $10.6M | Sell |
179,424
-63,100
| -26% | -$3.13M | 0.2% | 142 |
|
|
2021
Q3 | $10.4M | Sell |
242,524
-14,950
| -6% | -$662K | 0.2% | 142 |
|
|
2021
Q2 | $10.1M | Sell |
257,474
-20,700
| -7% | -$805K | 0.18% | 158 |
|
|
2021
Q1 | $10.1M | Sell |
278,174
-8,500
| -3% | -$302K | 0.19% | 154 |
|
|
2020
Q4 | $10.6M | Sell |
286,674
-671,701
| -70% | -$24.6M | 0.22% | 128 |
|
|
2020
Q3 | $33.4M | Sell |
958,375
-635,878
| -40% | -$22.3M | 0.77% | 5 |
|
|
2020
Q2 | $49.5M | Sell |
1,594,253
-314,724
| -16% | -$10.7M | 1% | 4 |
|
|
2020
Q1 | $59.1M | Sell |
1,908,977
-371,693
| -16% | -$12.7M | 1.35% | 2 |
|
|
2019
Q4 | $84.8M | Sell |
2,280,670
-218,389
| -9% | -$7.78M | 1.14% | 4 |
|
|
2019
Q3 | $85.2M | Buy |
2,499,059
+158,890
| +7% | +$5.78M | 1.18% | 4 |
|
|
2019
Q2 | $96.2M | Sell |
2,340,169
-65,137
| -3% | -$2.59M | 1.23% | 4 |
|
|
2019
Q1 | $96.9M | Sell |
2,405,306
-109,194
| -4% | -$4.37M | 1.21% | 7 |
|
|
2018
Q4 | $104M | Sell |
2,514,500
-16,232
| -0.6% | -$674K | 1.38% | 2 |
|
|
2018
Q3 | $106M | Buy |
2,530,732
+150,406
| +6% | +$5.79M | 1.03% | 5 |
|
|
2018
Q2 | $81.9M | Buy |
2,380,326
+338,228
| +17% | +$11.6M | 0.83% | 12 |
|
|
2018
Q1 | $68.8M | Sell |
2,042,098
-1,159
| -0.1% | -$39.8K | 0.74% | 26 |
|
|
2017
Q4 | $70.2M | Buy |
2,043,257
+24,579
| +1% | +$838K | 0.76% | 23 |
|
|
2017
Q3 | $68.4M | Sell |
2,018,678
-45,322
| -2% | -$1.46M | 0.78% | 19 |
|
|
2017
Q2 | $65.8M | Buy |
2,064,000
+1,627,787
| +373% | +$51.3M | 0.79% | 22 |
|
|
2017
Q1 | $14.2M | Sell |
436,213
-79,108
| -15% | -$2.49M | 0.17% | 123 |
|
|
2016
Q4 | $15.9M | Buy |
515,321
+8,121
| +2% | +$248K | 0.21% | 110 |
|
|
2016
Q3 | $16.3M | Sell |
507,200
-43,793
| -8% | -$1.46M | 0.24% | 107 |
|
|
2016
Q2 | $18.4M | Sell |
550,993
-74,233
| -12% | -$2.37M | 0.29% | 106 |
|
|
2016
Q1 | $17.6M | Buy |
625,226
+79,329
| +15% | +$2.27M | 0.3% | 119 |
|
|
2015
Q4 | $16.7M | Sell |
545,897
-3,109
| -0.6% | -$97.8K | 0.31% | 113 |
|
|
2015
Q3 | $16.4M | Sell |
549,006
-506,497
| -48% | -$16.2M | 0.34% | 96 |
|
|
2015
Q2 | $33.6M | Sell |
1,055,503
-62,695
| -6% | -$2.04M | 0.66% | 14 |
|
|
2015
Q1 | $36.9M | Sell |
1,118,198
-21,639
| -2% | -$688K | 0.76% | 9 |
|
|
2014
Q4 | $33.7M | Buy |
1,139,837
+7,589
| +0.7% | +$218K | 0.77% | 6 |
|
|
2014
Q3 | $31.8M | Buy |
1,132,248
+30,998
| +3% | +$870K | 0.8% | 7 |
|
|
2014
Q2 | $31M | Buy |
1,101,250
+276,459
| +34% | +$7.88M | 0.81% | 2 |
|
|
2014
Q1 | $25.1M | Buy |
824,791
+46,450
| +6% | +$1.38M | 0.72% | 6 |
|
|
2013
Q4 | $22.6M | Buy |
778,341
+28,468
| +4% | +$829K | 0.69% | 18 |
|
|
2013
Q3 | $20.4M | Buy |
749,873
+128,367
| +21% | +$3.49M | 0.7% | 16 |
|
|
2013
Q2 | $16.5M | Buy |
+621,506
| New | +$17.2M | 0.66% | 32 |
|
Other funds holding PFE
Bridgeway Capital Management's PFE Position: Q2 2025 in Review
Bridgeway Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 753,919 shares — an estimated $19.1M sold.
Bridgeway Capital Management first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $106M in Q3 2018. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Bridgeway Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Bridgeway Capital Management sold 753,919 Pfizer shares in Q2 2025, an estimated $19.1M.
- Bridgeway Capital Management first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
- Bridgeway Capital Management's Pfizer position peaked at $106M in Q3 2018.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.